Earnings call transcript: Mosaic posts Q3 2026 loss but shares jump on outlook

Mosaic reported Q3 adjusted EPS of -$0.19, missing the $0.01 consensus by $0.20, while revenue of $3.1 billion modestly exceeded the $3.08 billion forecast. Shares rose 9.83% to $20.23 after hours as investors focused on cost controls, improving demand signals and a Q4 sulfur contract at $615 per ton; management nevertheless expects Q4 to be the phosphate segment’s EBITDA trough as higher-cost inventory flows through. Mosaic cut 2026 capital spending to about $1.2 billion from $1.5 billion and targets below $1 billion in 2027, while forecasting 2027 SG&A below $500 million.

Analysis

The rally prices a faster margin recovery than the operating evidence yet supports. The key asymmetry is that Mosaic’s contracted sulfur advantage protects cash and preserves optionality, but it does not immediately lift reported phosphate margins: higher-cost inventory delays the benefit, while contract volumes cover only part of 2027 requirements. Marginal sulfur economics—not the headline contract price—will determine whether idle capacity returns. If spot sulfur remains elevated, lower CapEx is partly deferred maintenance and waste-storage spending, not a permanently lower cost base; a prolonged outage could leave Mosaic with less volume leverage when demand improves.

For the next quarter, management has already framed phosphate EBITDA as troughing, so a weak print alone may not invalidate the recovery case. The 1–3 month test is whether sulfur prices ease and phosphate netbacks improve enough to support sustained restarts. Over 6–18 months, under-application could support demand, but farmer affordability and actual crop yields—not management’s demand characterization—must validate that thesis. Potash offers a partial earnings cushion, though reported Baltic shipment losses may be delayed rather than permanently removed. Mosaic Biosciences is strategically interesting but too small, on the disclosed sales trajectory, to underwrite the consolidated recovery today.

Contrarian read: the market may be rewarding cash preservation and scarcity value while underweighting restart friction and the risk that elevated fertilizer prices suppress applications. After the sharp gap higher, near-term upside requires confirmation, not just another demand-positive narrative.

Key Decisions for Investors

• Do not chase the after-hours gap. Consider MOS on a pullback only if Gulf sulfur prices continue easing and phosphate netbacks improve; size it as a cyclical recovery position, not a proven earnings inflection.
• Use the next 1–3 months to monitor spot sulfur versus Mosaic’s contract coverage, phosphate realized margins, and any restart announcement. A sustained margin improvement sufficient to restart capacity would strengthen the long thesis; persistent high spot sulfur or continued curtailments would weaken it.
• Treat the Q4 earnings trough as partly inventory timing, but verify the next report shows lower-cost sulfur reaching cost of goods sold and improving phosphate margins. Cash-flow improvement without that earnings transmission is not confirmation of normalized economics.
• Watch potash contract negotiations and Baltic export data: evidence that disrupted tonnage is merely delayed, alongside weaker demand or affordability, would challenge the scarcity premium and could reverse the rally.